Table 1.
N | Min | Max | Mean | SD | |
---|---|---|---|---|---|
Control subjects | |||||
Age | 28 | 3 | 36 | 17.54 | 7.66 |
Height | 28 | 90 | 184 | 150.15 | 23.93 |
IGF-1 (ng/ml) | 28 | 106.0 | 380.0 | 233.00 | 76.98 |
IGF-1 (Log normal) | 28 | −0.718 | 0.89 | −0.04 | 0.35 |
IGFBP-3 (μg/ml) | 28 | 2.90 | 5.45 | 4.22 | 0.77 |
IGFBP-3 (Log normal) | 28 | −0.517 | 0.70 | −0.09 | 0.25 |
Patients | |||||
Age | 6 | 40 | 20.04 | 8.83 | |
Height (m) | 1.03 | 1.80 | 1.51 | 0.19 | |
Weight (kg) | 14.0 | 61.5 | 39.23 | 12.97 | |
Hemoglobin (g/dL) | 5 | 15 | 9.54 | 2.557 | |
Total WBC count (/cmm) | 1200 | 16700 | 5359.62 | 3618.18 | |
Platelets (/cmm) | 22000 | 310000 | 146250.00 | 75886.78 | |
Albumin (g/dl) | 2.5 | 34.0 | 4.21 | 4.33 | |
Spleen size at ultrasonography (cm) | 9 | 25 | 16.76 | 4.04 | |
IGF-1 (ng/ml) | 52 | 25.0 | 392.0 | 124.71* | 65.48 |
IGF-1 (Log normal) | 52 | −2.06 | 0.03 | −0.78* | 0.61 |
IGFBP-3 (μg/ml) | 52 | 1.0 | 5.0 | 2.90* | 1.07 |
IGFBP-3 (Log normal) | 52 | −1.84 | 0.33 | −0.61* | 0.45 |
* P = 0.001 as compared to control subjects